It is time for drug professionals, including the harm reduction community, to have a say about the upcoming regulation of the European cannabis market. If not, we miss an important historical opportunity to shape the future.
The Correlation European Harm Reduction Network published its first monitoring report (download here!) of harm reduction in Europe. On this occasion, we interviewed Eberhard Schatz, one of the two coordinators of the network about new trends and challenges.
Many people know the story of the drunkard from Saint-Exupéry’s Little Prince, who drinks because he is ashamed, and is ashamed because he drinks. This article is about how ancient wisdom and modern science teach us to avoid shaming as a tool to change people.
What is your style in advocacy? Are you a rational owl, an activist elephant, a barking watchdog, or a sly old fox? This article will help you to navigate the zoo.
The overdose epidemic in Scotland attracted international media attention but we know less about what is the situation in other parts of the UK. We interviewed Martin Balekbrough, the CEO of the Kaleidoscope Project from Wales.
Although the drug strategy adopted by the Hungarian government in 2013 aimed to make the country drug-free by 2020, the (not so) new synthetic drugs still rule the country. After the municipal elections, there is some hope that harm reduction can return to Budapest.
I agree with Carl Hart (read here!) that people who use psychedelics should not look down on stimulant or opiate users. Using different drugs doesn’t make them better or more virtuous persons. But I disagree with claims that methamphetamine or heroin is no more dangerous than cannabis or LSD.
It is not our search for pleasure that is so damaging to the environment, but corporal greed, social injustice, and inequality.
In this report we present four best practices in the field of drug demand and harm reduction from three countries. With this report, we would like to promote the culture of evaluation both among civil society organisations and decision makers.
This movie follows Sithu Min Than, a young man from Kachin State in Myanmar, struggling to recover with the help of opiate substitution treatment.